Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 842, pseudogene (RN7SL842P) is a non-functional, noncoding RNA pseudogene derived from the 7SL RNA, which is a key RNA component of the signal recognition particle (SRP) complex[4][2][6][7]. The authentic 7SL RNA is essential for targeting newly synthesized proteins to the endoplasmic reticulum, but RN7SL842P lacks the ability to encode a functional product and is not known to be transcribed or functional in cellular physiology[2][6][7]. Pseudogenes such as RN7SL842P are typically formed by genomic insertion of reverse-transcribed RNA and are generally considered evolutionary remnants with limited regulatory impact; they are not classified as therapeutic targets and have no established molecular or disease-related role[2][4][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 842, pseudogene (RN7SL842P).